Literature DB >> 32255378

MBTPS2 exacerbates albuminuria in streptozotocin-induced type I diabetic nephropathy by promoting endoplasmic reticulum stress-mediated renal damage.

Yongliang Liu1, Dayu Xu2, Linping Wang1, Wenyan Du1, Limei Zhang3, Xinxin Xiang1.   

Abstract

BACKGROUND: The membrane-bound transcription factor protease site 2 (MBTPS2) is an intramembranous metalloprotease involved in the regulation of ER stress response, however, whether it is associated with DN is unknown.
RESULTS: We report that MBTPS2 expression is upregulated in the renal cortex of diabetic mice induced by streptozotocin (STZ), a murine model of insulinopenic type 1 DN. Functionally, in vivo, MBTPS2 overexpression exacerbates and its knockdown attenuates albuminuria, which indicate a detrimental role of MBTPS2 played in albuminuria development in DN mice. We further show that MBTPS2 promotes ER stress and renal damage in DN mice, and that reducing ER stress via a chemical chaperone 4-phenylbutyric acid (4-PBA) markedly rescues MBTPS2-exacerbated renal damage and albuminuria severity.
CONCLUSIONS: Collectively, our study associates the function of MBTPS2 in DN albuminuria with ER stress regulation, thus underscoring the notorious role of maladaptive ER response in influencing DN albuminuria.

Entities:  

Keywords:  Albuminuria; ER stress; MBTPS2; Streptozotocin; diabetic nephropathy; renal damage

Mesh:

Substances:

Year:  2020        PMID: 32255378     DOI: 10.1080/13813455.2020.1749084

Source DB:  PubMed          Journal:  Arch Physiol Biochem        ISSN: 1381-3455            Impact factor:   3.188


  2 in total

Review 1.  Relationship between lysosomal dyshomeostasis and progression of diabetic kidney disease.

Authors:  Man Wu; Minjie Zhang; Yaozhi Zhang; Zixian Li; Xingyu Li; Zejian Liu; Huafeng Liu; Xiaoyu Li
Journal:  Cell Death Dis       Date:  2021-10-18       Impact factor: 8.469

2.  A Novel Risk Model Based on Autophagy Pathway Related Genes for Survival Prediction in Lung Adenocarcinoma.

Authors:  Fan Zhang; Suzhen Xie; Zhenyu Zhang; Huanhuan Zhao; Zijun Zhao; Haiying Sun; Jiao Zheng
Journal:  Med Sci Monit       Date:  2020-09-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.